Publication | Closed Access

Usefulness of Highly Sensitive Troponin as a Predictor of Short-Term Outcome in Patients With Diabetes Mellitus and Stable Coronary Artery Disease (from the ARTEMIS Study)

InflammationMetabolic SyndromeDiabetes ManagementHighly Sensitive TroponinCardiovascular DiseaseDiabetesHyperlipidemiaArtemis StudyDiabetes MellitusMedicineAtherosclerosisDyslipidemia